课题基金 / 基金详情

Prevalence, Consequences and Mechanisms of Antibiotic Heteroresistance in Cystic Fibrosis

Prevalence, Consequences and Mechanisms of Antibiotic Heteroresistance in Cystic Fibrosis
囊性纤维化抗生素异抗性的患病率、后果和机制
批准号:
10686807
负责人:
PRADEEP k SINGH
金额:
$59.07万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-01 至 2026-08-31

项目摘要

项目成果

PRADEEP k SINGH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary Progress in improving infection outcomes depends upon understanding factors that diminish antibiotic action. Recent work suggests antibiotic heteroresistance may be a key factor. Heteroresistant pathogens exhibit population-level resistance heterogeneity, meaning they contain highly resistant subpopulations, and often exhibit unstable resistance, meaning some cells become rapidly sensitive when grown without antibiotics. This proposal focuses on these two phenotypes as they are postulated to have major effects on susceptibility testing and antibiotic efficacy. Here we propose to study population-level resistance heterogeneity and unstable resistance in people with cystic fibrosis (CF) and chronic Pseudomonas aeruginosa (Pa) infections who cycle on and off inhaled tobramycin. CF offers key advantages for these studies as it is a monogenic disease with uniform manifestations, the responses of a single bacterial species to the same antibiotic can be studied in sizable cohorts, and infrastructure exists to procure primary specimens from the infected site (sputum) during antibiotic "on" and "off" periods. These advantages, and methods developed in our preliminary work enable us to test the hypotheses that Pa from chronically-infected patients exhibit marked population-level resistance heterogeneity and unstable resistance; that parameters accounting for these factors predict clinical responses to treatment; and that unstable resistance in CF Pa is due to a core set of gene amplifications and fitness-compensating point mutations. This work will generate foundational knowledge about antibiotic heteroresistance that could improve understanding of antibiotic treatment failure in CF, and suggest new precision medicine approaches to select antibiotics and improve outcomes. The findings could also guide future work in infections where patient heterogeneity, pathogen and treatment diversity, and less developed infrastructure make studies more difficult.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Prevalence, Consequences and Mechanisms of Antibiotic Heteroresistance in Cystic Fibrosis
  • 批准号:
    10339853
  • 项目类别:
  • 资助金额:
    $64.56万
  • 财政年份:
    2022
  • 负责人:
    PRADEEP k SINGH
  • 依托单位:
Using infecting population dynamics to understand chronic cystic fibrosis infecti
  • 批准号:
    8324800
  • 项目类别:
  • 资助金额:
    $47.56万
  • 财政年份:
    2011
  • 负责人:
    PRADEEP k SINGH
  • 依托单位:
Studies on bacterial populations and new therapeutics for CF lung infections
  • 批准号:
    8323328
  • 项目类别:
  • 资助金额:
    $17.62万
  • 财政年份:
    2010
  • 负责人:
    PRADEEP k SINGH
  • 依托单位:
Pilot and Feasibility program
  • 批准号:
    9982663
  • 项目类别:
  • 资助金额:
    $42.65万
  • 财政年份:
    2010
  • 负责人:
    PRADEEP k SINGH
  • 依托单位:
海外基金